Integra Lifesciences (IART) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Integra Lifesciences (IART) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Integra Lifesciences

· IART

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.251 B

-21.19%

General

Market Cap: $1.25B
Enterprise Value: $2.81B
Shares Outstanding: 77,770,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 53.74%
Operating Margin: 39.81%
Net Profit Margin: -0.44%
FCF Margin: 2.35%
ROA: -0.20%
ROE: -0.69%
ROIC: 19.92%
Current Ratio: 3.40
Debt-to-Equity: 1.94
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 0.60
P/FCF: 25.45
P/B: 0.94
EV/EBITDA: 11.30

Growth

Rev 1Y: 1.53%
Rev 1Y Fwd Est: 2.26%
Rev 3Y (CAGR): 1.63%
Rev 5Y (CAGR): 3.57%

Income Statement (TTM)

Revenue: $1.65B
Gross Margin: 53.74%
Operating Expenses: $229.59M
Operating Income: $655.86M
Net Profit: -$7.24M

Balance Sheet

Rev 10Y (CAGR)

6.36%

EPS 1Y

—

EPS 1Y Fwd Est

—

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $214.42M
Working Capital: $833.5M
Total Assets: $3.59B
Net Debt: $1.83B
Total Liabilities: $2.54B
Total Equity: $1.05B

Cash Flow Statement (TTM)

Cash Flow from Operations: $85.33M
Cash Flow from Investing: -$108.63M
Cash Flow from Financing: $20.82M
Free Cash Flow: $38.76M
Capital Expenditures: $46.57M